目的 报道1例中年女性胰腺实性假乳头状肿瘤病例,并通过文献回顾和复习,提高临床医生对此类罕见病的认识,减少该疾病的误诊、漏诊。方法 回顾性分析1例中年女性胰腺实性假乳头状肿瘤的诊治经过,结合以往的文献报道,总结该疾病的临床表现、诊治方法。结果 回顾文献显示:胰腺实性假乳头状肿瘤比较罕见,好发于年轻女性,属于低度恶性肿瘤。本例患者38岁女性,因腹痛入院。术后病理证实为胰腺实性假乳头状肿瘤。随访1年,未见明显复发和转移征象。结论 胰腺实性假乳头状肿瘤临床表现无特异性,诊断主要依靠影像学检查和组织病理学结果。手术切除是胰腺实性假乳头状肿瘤首选治疗手段。

Objective To report a case of solid pseudopapillary tumor of the pancreas and review literatures about this disease, so as to improve clinical understanding of this rare disease and reduce misdiagnosis and missed diagnosis. Methods The clinical manifestation,diagnosis and treatment of the patient with solid pseudopapillary tumor of the pancreas were analyzed retrospectively. The clinical manifestation and key points of diagnosis were summarized from literature review. Results Literature review showed that: solid pseudopapillary tumor of the pancreas is a rare low-grade malignancy tumors, which frequently occurs in young women. This case is a thirty-eight years old female patient who was admitted to the hospital due to abdominal pain. Postoperative pathology confirmed a solid pseudopapillary tumor of the pancreas. Follow-up of 1 year showed no obvious signs of recurrence and metastasis. Conclusion Solid pseudopapillary tumor of the pancreas has no specific clinical manifestations, the diagnosis mainly depends on imaging examination and histopathological results. Surgical resection is the preferred treatment for solid pseudopapillary tumors of the pancreas.

瘦素是维持人体能量代谢平衡的蛋白质,在人体中主要由白色脂肪组织分泌,通过与瘦素受体结合发挥作用。近年来有许多与瘦素相关的研究证明高血压患者及代谢综合征患者的血清瘦素水平较健康人群明显升高。两种疾病均可出现心室肥厚,蛋白尿,动脉粥样硬化等表现,说明二者存在共同的靶器官。瘦素代谢异常可出现瘦素抵抗并通过影响肾素-血管紧张素-醛固酮系统(renin angiotensin aldosterone system, RAAS)及炎症细胞因子来损伤靶器官。本文旨在总结瘦素在高血压及代谢综合征中的作用机制,并探讨瘦素对高血压合并代谢综合征靶器官损伤作用的研究进展。

Leptin is a protein that maintains the balance of energy metabolism in human body. It is mainly secreted by white adipose tissue in human body. In recent years, many studies have shown that the serum leptin level in patients with hypertension complicated with metabolic syndrome is significantly higher than that of healthy people. Both of the diseases can lead to left ventricular hypertrophy, proteinuria, atherosclerosis and other manifestations. The abnormal metabolism of leptin may contribute to leptin resistance which damages target organs by affecting the angiotensin aldosterone system and inflammatory cytokines. The aim of this article is to summarize the mechanism of leptin in hypertension and metabolic syndrome, and to explore its effect on the target organ damage in patients with hypertension complicated with metabolic syndrome.

       目的   通过分析广州某三甲医院临床试验用药品规范管理体系构建前后试验用药品超温次数及质控发现缺陷项数量变化情况，为药物临床试验规范开展提供参考。方法   结合某医院临床试验用药品管理实践，以试验用药品超温次数、质控发现缺陷项数量占项目比为评价指标，使用卡方检验进行比较。结果   某医院实施临床试验用药品规范管理体系后，发生试验用药品超温次数由实施前的9次下降至3次，呈明显下降趋势，2018—2020年试验用药品管理方面质控发现缺陷项数量占项目比为70.25%，2021—2023年占项目比为18.90%，实施前后组间比较差异有统计学意义（P＜0.001）。结论   构建临床试验用药品规范管理体系，可以减少试验用药品超温次数和试验用药品管理方面质控发现缺陷项数量，从而保证药物临床试验的质量。

       Objective   To analyze the changes in the number of excessive temperature incidents and the proportion of quality control issues in drug management before and after the establishment of construction and practice of standardized management system in a tertiary hospital in Guangzhou，to provide a reference for drug clinical trials standard development．Methods  Based on the management practice of investigational medicinal products from a hospital，the number of excessive temperature incidents and the proportion of quality control issues in drug management were taken as evaluation index and compared using chi-square tests．Results  After implementing the standardized management system for investigational drugs，the number of temperature exceeding incidents decreased from 9 times to 3 times，showing an obvious decreasing trend，and from 2018 to 2020，the  proportion of quality control issues in drug management accounted for 70.25%，while from 2021 to 2023，it accounted for 18.90%．There was a statistically significant difference between the groups before and after the implementation（P＜0.001）．Conclusions  The establishment of  standardized management  system for investigational medicinal  products can  reduce the  number of excessive temperature incidents and the proportion of quality control issues in drug management，and ensure the quality of drug clinical trials．